Welcome to Crene Biotechnology!


Product :

Foretinib GSK1363089

Foretinib GSK1363089 849217-64-7
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:Foretinib GSK1363089 Purity:98% min
CAS NO:849217-64-7 Solubility:DMSO : ≥ 38 mg/mL (60.06 mM)
Molecular Formula:C34H34F2N4O6 Package:Package according to customer requirements
Molecular Weight:632.654 Storage:Store at -20℃
Quality control

Foretinib, also known as XL880 and GSK1363089, is an orally bioavailable small molecule with potential antineoplastic activity. MET/VEGFR2 inhibitor GSK1363089 binds to and selectively inhibits hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of tumor angiogenesis, tumor cell proliferation and metastasis. The proto-oncogene c-MET has been found to be over-expressed in a variety of cancers.



Density: 1.372g/cm3

Boiling Point: 828.475ºC at 760 mmHg

Flash Point: 454.846ºC

Refractive Index: 1.649




Related Prodcuts:

LY2874455; ZM-306416; ZM323881; Tyrphostin A9; Orantinib; Brivanib; SU5402; Semaxanib; SAR131675; Lucitanib; Apatinib; SKLB610; Altiratinib; SGI-7079; AZD2932

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China